Table 2.
Mean levels of basal perfusion pressure of the both rats’ strain (SHR and WKY) treated with egg-lecithin (SL) and not treated control group (C).
| SHR-SL (n = 15) | SHR-C (n = 15) | WKY-SL (n = 11) | WKY-C (n = 11) | |
|---|---|---|---|---|
| Mean ± SEM | Mean ± SEM | Mean ± SEM | Mean ± SEM | |
| PP 1 [mmHg] | 52.48* ± 1.09 | 62.04 ± 1.74 | 50.01* ± 1.56 | 41.30 ± 1.55 |
| PP 2 [mmHg] - Infusion NE | 86.81*A ± 2.72 | 101.32A ± 2.67 | 58.95A ± 1.94 | 60.01A ± 2.68 |
| PP 3 [mmHg]- Infusion NE + L-NOARG | 91.94* ± 3.07 | 114.16B ± 3.70 | 54.22 ± 1.55 | 60.90 ± 2.78 |
| PP T [mmHg] | 76.75* ± 1.68 | 92.20 ± 2.04 | 53.52 ± 0.97 | 53.54 ± 1.47 |
PP1 [mmHg] – basal perfusion pressure in the first stage of the study. PP2 [mmHg] - perfusion pressure during the infusion NE, second stage of study. PP3 [mmHg] - basal perfusion pressure during the infusion NE + L-NOARG, third stage of study. PPT [mmHg] - mean basal perfusion pressure of all perfusions’ stages. *P < 0.05, compared to the control group (SL vs. C). AP < 0.05, significant increase of perfusion pressure inside the group caused by NE infusion (PP1 vs. PP2). BP < 0.05, significant increase of perfusion pressure inside the group caused by NE + L-NOARG infusion (PP2 vs. PP3).